SpringLeaf Therapeutics, a Boston-based device-delivery company, emerged from stealth mode last week with the announcement of a $15 million Series B financing round led by the corporate venture capital arm of...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)